Policy Comments

The priority legislative and regulatory issues that the Cancer Policy Institute focuses on are driven by policy pillars that are centered around the values, needs, and preferences of individuals impacted by cancer. We work in conjunction with patients, patient advocacy organizations, medical associations, and other stakeholders to advance policies aimed at improving access to, affordability of, and quality of care across the cancer continuum.

    Group Letter To HHS In Support Of The Verifying Accurate Leading Edge IVCT Development (VALID) Act (April 2022)
    FDA, Access to Innovative Treatment
    Coalition Letter To Healthy Future Task Force Treatment Subcommittee On Medicare's Six Protected Classes (March 2022)
    Access to Affordable, Comprehensive Care, Medicare, Medicaid, and Private Health Insurance Coverage
    CSC Letter To National Cancer Institute In Response To Request For Information On Priorities For Cancer Control And Population Sciences (March 2022)
    21st Century Cures, Access to Innovative Treatment, Cancer Research, Health Equity, Patient Experience, Telehealth
    CSC Letter To Representatives Matsui And Wenstrup On Cures 2.0 Act And Patient Experience Data In Clinical Trials (March 2022)
    21st Century Cures, Patient Experience, Cancer Research, Clinical Trials, FDA
    CSC Letter To The Healthy Future Task Force’s Modernization Subcommittee Request For Information (March 2022)
    Telehealth, Clinical Trials
    Group Letter To Congress In Support Of The Reducing Hereditary Cancer Act (March 2022)
    Access to Affordable, Comprehensive Care, Medicare, Medicaid, and Private Health Insurance Coverage
    Group Letter To Congressional Leaders In Support Of H.R.7213 Equitable Community Access To Pharmacist Services Act

    Support of the passage of H.R. 7213, the Equitable Community Access to Pharmacist Services Act, to secure patient access to pharmacy services and permanently provide pharmacists the ability to care for those in need during this and future pandemics.

    Access to Affordable, Comprehensive Care
    Coalition Comments To The Healthy Future Task Force’s Affordability Request For Information (February 2022)
    Access to Affordable, Comprehensive Care, Affordable Care Act, Medicare, Medicaid, and Private Health Insurance Coverage, Section 1332 Waivers, Medicaid Section 1115 Waivers
    Coalition Letter Re: Massachusetts' 1115 Demonstration Waiver (February 2022)
    Medicaid Section 1115 Waivers, Medicare, Medicaid, and Private Health Insurance Coverage
    Coalition Letter To Congress Urging The Inclusion Of Health Priorities In The FY22 Budget Reconciliation Process (February 2022)
    COVID-19, Access to Affordable, Comprehensive Care, Affordable Care Act, Medicare, Medicaid, and Private Health Insurance Coverage